未找到相关数据
A phase I clinical trial of riluzole in combination with mFOLFOX6 and bevacizumab in treating patients with metastatic colorectal cancer.
被引：0
作者：
Li, Chunjie
Noonan, Anne M.
Hays, John L.
Roychowdhury, Sameek
Malalur, Pannaga G.
Elkhatib, Rifat T.
Manne, Ashish
Mittra, Arjun
Rahman, Shafia
Phelps, Mitch A.
Liang, Beiyuan
Storts, Hadyen
Khan, Misbah
Zhang, Evan
Zheng, Xinru
Miles, Wayne
Wang, Jing
Jin, Ning
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
[2] James Canc Hosp, Columbus, OH USA
[3] Solove Res Inst, Columbus, OH USA
[4] Ohio State Univ, James Canc Hosp, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[6] Ohio State Univ, Columbus, OH USA
[7] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH USA
关键词：
283-237-255-11316;
261-492-3532-2370-5109;
261-492-199-2823;
613-615-646-4685-2424;
261-492-5651-5481;
3;
2;
182;
1834;
1700;
54;
4;
38116-38094-8;
38092-20125;
D O I：
10.1200/JCO.2024.42.3_suppl.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文